Back to Search
MANUEL MODIANO M.D.
M.D.
Hematology & Oncology Physician
NPI: 1003864380IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
17060(AZ)
Education
OTHER
Class of 1982
Research & Publications (17)
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.
PMID 17325899·Leuk Lymphoma·2007
3-trial
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
PMID 16983112·J Clin Oncol·2006
3-trial
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer.
PMID 16487997·Gynecol Oncol·2006
3-trial
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.
PMID 15744588·Invest New Drugs·2005
3-trial
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
PMID 15447994·Clin Cancer Res·2004
3-trial
Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
PMID 12855611·Clin Cancer Res·2003
8-other
Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant.
PMID 12697866·J Clin Oncol·2003
3-trial
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
PMID 14519631·Clin Cancer Res·2003
3-trial
Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule.
PMID 12203104·Cancer Chemother Pharmacol·2002
3-trial
ZD0473 treatment in lung cancer: an overview of the clinical trial results.
PMID 12645908·Eur J Cancer·2002
1-meta
Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer.
PMID 12441935·J Urol·2002
3-trial
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
PMID 11863117·Ann Oncol·2002
3-trial
Mitoxantrone and paclitaxel combination chemotherapy in metastatic breast cancer.
PMID 11338878·Cancer Invest·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2115 W 16th St
Safford, AZ 85546 - Phone
- (520) 689-7030
Quick Facts
- NPI
- 1003864380
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 44
- Publications
- 17
Are you this provider?
Claim Your Profile